Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Carleton

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Pediatric Transplantation|December 30, 2022
Noninvasive testing for mycophenolate exposure in children with renal transplant using urinary metabolomicsKhalid Taha, Atul Sharma, Kristine Kroeker, et al.
Annals of the New York Academy of Sciences|October 4, 2007
Genotypic approaches to therapy in children: a national active surveillance network (GATC) to study the pharmacogenomics of severe adverse drug reactions in childrenColin J D Ross, Bruce Carleton, Dana G Warn, et al.
Paediatrics & Child Health|May 18, 2018
Response to <i>The routine use of oral steroids in paediatric asthma is not routine</i>Neale Smith, Alice Wang, Kaitlyn Shaw, et al.
The Pharmacogenomics Journal|November 20, 2024
Implementation of pharmacogenetic testing in pediatric oncology: barriers and facilitators assessment at eight Canadian academic health centresJeanette Cooper, Joshua Pratt, Jamie Park, et al.
Pediatric Blood & Cancer|December 23, 2017
An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclinesFrancois Dionne, Folefac Aminkeng, Amit P Bhavsar, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|April 7, 2011
Pharmacogenomics of serious adverse drug reactions in pediatric oncologyColin J D Ross, Henk Visscher, S Rod Rassekh, et al.
Therapeutic Drug Monitoring|July 23, 2020
Pharmacokinetic-Pharmacogenomic Model for Chinese Children Treated With Lamotrigine Also Applies for Mexican ChildrenJosé Eduardo Juárez-Hernández, Michel Gutiérrez-Ceniceros, José Rodrigo González-Ramírez, et al.
Plos One|September 9, 2021
An observational cohort study comparing ibuprofen and oxycodone in children with fracturesSamina Ali, Robin Manaloor, David W Johnson, et al.
Drug Safety|December 18, 2024
Advances in Drug Safety: Highlights from the 23rd Annual Meeting of the International Society of PharmacovigilanceOmar Aimer, Maribel Salas, Tarek A Hammad, et al.
BMJ Open|June 4, 2017
Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case-control study protocol for dimethyl fumarate-induced lymphopeniaKaarina Kowalec, Elaine Kingwell, Robert Carruthers, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Pediatric Transplantation|December 30, 2022
Noninvasive testing for mycophenolate exposure in children with renal transplant using urinary metabolomicsKhalid Taha, Atul Sharma, Kristine Kroeker, et al.
Annals of the New York Academy of Sciences|October 4, 2007
Genotypic approaches to therapy in children: a national active surveillance network (GATC) to study the pharmacogenomics of severe adverse drug reactions in childrenColin J D Ross, Bruce Carleton, Dana G Warn, et al.
Paediatrics & Child Health|May 18, 2018
Response to <i>The routine use of oral steroids in paediatric asthma is not routine</i>Neale Smith, Alice Wang, Kaitlyn Shaw, et al.
The Pharmacogenomics Journal|November 20, 2024
Implementation of pharmacogenetic testing in pediatric oncology: barriers and facilitators assessment at eight Canadian academic health centresJeanette Cooper, Joshua Pratt, Jamie Park, et al.
Pediatric Blood & Cancer|December 23, 2017
An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclinesFrancois Dionne, Folefac Aminkeng, Amit P Bhavsar, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|April 7, 2011
Pharmacogenomics of serious adverse drug reactions in pediatric oncologyColin J D Ross, Henk Visscher, S Rod Rassekh, et al.
Therapeutic Drug Monitoring|July 23, 2020
Pharmacokinetic-Pharmacogenomic Model for Chinese Children Treated With Lamotrigine Also Applies for Mexican ChildrenJosé Eduardo Juárez-Hernández, Michel Gutiérrez-Ceniceros, José Rodrigo González-Ramírez, et al.
Plos One|September 9, 2021
An observational cohort study comparing ibuprofen and oxycodone in children with fracturesSamina Ali, Robin Manaloor, David W Johnson, et al.
Drug Safety|December 18, 2024
Advances in Drug Safety: Highlights from the 23rd Annual Meeting of the International Society of PharmacovigilanceOmar Aimer, Maribel Salas, Tarek A Hammad, et al.
BMJ Open|June 4, 2017
Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case-control study protocol for dimethyl fumarate-induced lymphopeniaKaarina Kowalec, Elaine Kingwell, Robert Carruthers, et al.
Pageof 11